Diff view

Codes in RHS only

• Beta source contact therapy (5962.)
• Betatron electron therapy (5932.)
• Betatron photon therapy (5922.)
• Combined X-ray therapy (5918.)
• Combined fast-electron therapy (5934.)
• Combined heavy particle therapy (5946.)
• Combined photon therapy (5924.)
• Combined teletherapy and intermediate distance curietherapy (5953.)
• Deep X-ray therapy 150-400 kV (5914.)
• Deuteron therapy (5942.)
• External beam - surgery with chemotherapy (5974.)
• External beam - surgery with postoperative radiotherapy (5973.)
• External beam - surgery with preoperative radiotherapy (5972.)
• External beam with chemotherapy (5975.)
• External beam with internal radiotherapy (5971.)
• Fast neutron therapy (5945.)
• Gamma-ray telecurie therapy (5951.)
• Grenz ray therapy up to 10 kV (5911.)
• Half-deep therapy 60-150 kV (5913.)
• Intermediate distance curietherapy (5952.)
• Intracavitary X-ray therapy (5917.)
• Linear accelerator electrons (5931.)
• Linear accelerator photon therapy (5921.)
• Mould technique gamma/beta (5963.)
• Neutron capture therapy (5944.)
• Palliative course of radiotherapy (5149.)
• Pi-meson therapy (5943.)
• Positron therapy (5933.)
• Postoperative course of radiotherapy (5146.)
• Preoperative course of radiotherapy (5144.)
• Proton therapy (5941.)
• Radiological tumour control (5135.)
• Radiotherapy - intraoperative control (5145.)
• Radiotherapy changed (5152.)
• Radiotherapy completed (5154.)
• Radiotherapy for analgesia (5147.)
• Radiotherapy for haemopoietic irradiation (5142.)
• Radiotherapy for immunosuppression (5141.)
• Radiotherapy for inflammation (5148.)
• Radiotherapy for lymphatic irradiation (5143.)
• Radiotherapy started (5151.)
• Radiotherapy stopped (5153.)
• Radium contact therapy (5961.)
• Short distance X-ray therapy (5916.)
• Superficial X-ray therapy 10-60 kV (5912.)
• Ultrahard X-rays 400-2000 kV (5915.)
• Van der Graaff photon therapy (5923.)

Codes in common

• Admit radiotherapy emergency (8H2G.)
• Adverse reaction to antineoplastic antibiotics (TJ07.) with these descendants
  • Adverse reaction to actinomycin D (TJ070)
  • Adverse reaction to antineoplastic antibiotics NOS (TJ07z)
  • Adverse reaction to bleomycin (TJ071)
  • Adverse reaction to doxorubicin hydrochloride (TJ072)
  • Adverse reaction to mitomycin (TJ073)
  • Adverse reaction to plicamycin (TJ074)
• Adverse reaction to antineoplastic/immunosuppress drugs NOS (TJ31z)
• Adverse reaction to busulfan (TJ310)
• Adverse reaction to carboplatin (TJ31J)
• Adverse reaction to carmustine (TJ311)
• Adverse reaction to chlorambucil (TJ312)
• Adverse reaction to chlormethine hydrochloride (TJ317)
• Adverse reaction to cisplatin (TJ31K)
• Adverse reaction to cyclophosphamide (TJ313)
• Adverse reaction to cytarabine (TJ31A)
• Adverse reaction to estramustine phosphate (TJ314)
• Adverse reaction to etoposide (TJ31F)
• Adverse reaction to fluorouracil (TJ31B)
• Adverse reaction to hydroxycarbamide (TJ31L)
• Adverse reaction to lomustine (TJ315)
• Adverse reaction to melphalan (TJ316)
• Adverse reaction to mercaptopurine (TJ31C)
• Adverse reaction to methotrexate (TJ31D)
• Adverse reaction to mitoxantrone (TJ31M)
• Adverse reaction to procarbazine (TJ31N)
• Adverse reaction to razoxane (TJ31P)
• Adverse reaction to thiotepa (TJ318)
• Adverse reaction to tioguanine (TJ31E)
• Adverse reaction to treosulphan (TJ319)
• Adverse reaction to vinblastine sulphate (TJ31G)
• Adverse reaction to vincristine sulphate (TJ31H)
• Antineoplastic antibiotic poisoning (SL07.) with these descendants
  • Accidental daunorubicin poisoning (Xa4sx)
  • Antineoplastic antibiotic poisoning NOS (SL07z)
  • Cactinomycin poisoning (SL070)
  • Daunorubicin poisoning (SL073)
  • Daunorubicin poisoning of undetermined intent (Xa4sz)
  • Intentional daunorubicin poisoning (Xa4sy)
• Aplastic anaemia due to radiation (D2013)
• Bile duct endoluminal radiotherapy (X20by)
• Cancer chemotherapy management plan (XaVwB)
• Chemotherapy (X71bL) with these descendants
  • Ambulatory chemotherapy (XaI8k)
  • Cancer chemotherapy (8BAD0)
  • Chemotherapy delivery (XaM49)
  • Combined post-operative chemotherapy and radiotherapy (XaImf)
  • Combined pre-operative chemotherapy and radiotherapy (XaIme)
  • Del comp chemo neo inc prolong infusion treat first attend (XaM4B)
  • Deliv complex parenteral chemotherapy neopl first attendance (XaM4C)
  • Deliver simple parenteral chemother neoplas first attendance (XaM4D)
  • Delivery of chemotherapy for neoplasm (XaM4A)
  • Delivery of chemotherapy for neoplasm NOS (XaM4G)
  • Delivery of exclusively oral chemotherapy for neoplasm (XaM4I)
  • Delivery of oral chemotherapy for neoplasm (XaM4H)
  • Delivery of oral chemotherapy for neoplasm NOS (XaM4L)
  • Delivery subsequent element cycle chemotherapy for neoplasm (XaM4E)
  • Electrochemotherapy (XaZWZ)
  • Intravenous chemotherapy (XE0Jb)
  • Neoadjuvant chemotherapy (XaZD3)
  • Oral chemotherapy (XE0hv)
  • Oral chemotherapy (& cytotoxic) (8BA5.)
  • Other specified delivery of chemotherapy for neoplasm (XaM4F)
  • Other specified delivery of oral chemotherapy for neoplasm (XaM4J)
  • Post-operartive chemotherapy (XaIkz)
  • Pre-operative chemotherapy (XaIky)
  • Prophylactic chemotherapy (XE1Sk)
  • Prophylactic chemotherapy NOS (65NZ.)
  • TB chemotherapy (8BAD1)
• Chemotherapy follow-up (8HB7.)
• Chemotherapy started (XaKwV)
• Combined therapy follow-up (8HB5.)
• Continuous infusion of chemotherapy (XaC0F)
• Cytotoxic drug therapy NOS (Xa3yn)
• Cytotoxic given orally (Xa3yl)
• Diagnostic intravenous injection of Camsilon (XaC0n)
• Electromagnetic energy therapy (XaECT) with these descendants
  • Pulsed electromagnetic energy therapy (Ub1Pe)
• Endoscopic radiofrequency ablation of lesion of prostate (XaMAv)
• High cost chemotherapy drugs (Xaaw6)
• Image: field control:radiother (56B5.)
• Implantation of radioactive substance into pituitary gland (71011)
• Implantation of radioactive substance into vagina (7D154)
• Implantation of radioactive substance into vulva (7D034)
• Intramuscular chemotherapy (XE0Jc)
• Intramuscular injection of Methotrexate (XaC0G)
• Intramuscular injection of betamethasone (XaDzO)
• Intramuscular injection of methylprednisolone (XaJr8)
• Intraperitoneal administration of radioactive substance (7H2C0)
• Intrathecal injection of chemotherapeutic agent (70462)
• Intravenous injection of Methotrexate (XaC0H)
• Intro non-remov radioact subst into organ for brachyther NOC (XaPvn)
• Intro radioactive substance into organ for brachytherapy NOC (XaPvm)
• Introduction of radioactive substance into uterine cavity (7E0C0)
• Introduction removable radioactive material into organ NOC (7M0P.) with these descendants
  • Intro radioactive substance org interstit brachytherapy NOC (XaLyX)
  • Introduction of iridium wire into organ NOC (7M0P1)
  • Introduction of radioactive caesium into organ NOC (7M0P0)
  • Introduction of radium into organ NOC (7M0P2)
  • Introduction removable radioactive material to organ NOC OS (7M0Py)
• Introduction removable radioactive material to organ NOC NOS (7M0Pz)
• Neutropenia due to irradiation (XE14D)
• Non-urgent radiotherapy admission (8H3L.)
• Overdose of radiation in therapy (TA32.)
• Percutaneous radiofrequency ablation of lesion of bone (XaPt9)
• Percutaneous radiofrequency ablation of lesion of kidney (XaM4w)
• Percutaneous radiofrequency ablation of lesion of liver (XaLdr)
• Percutaneous radiofrequency ablation of lesion of lung (XaMlE)
• Phototherapy &/or radiation therapy (863..)
• Progress of radiotherapy (515..) with these descendants
  • Awaiting radiotherapy (XaIR9)
  • Radiotherapy progress NOS (515Z.)
• Radiation/phototherapy NOS (863Z.)
• Radioactive seed implantation NOC (XaLyT)
• Radioactive seed implantation into prostate (XaMv7)
• Radiotherapy implant: [needles] or [therapy] (5A4..)
• Radiotherapy of corneal lesion (72444)
• Radiotherapy procedure with complication, without blame (TB121)
• Radiotherapy procedures (Ub0w0) with these descendants
  • (Radiotherapy - internal) or (other nuclear therapy) (5A...)
  • Afterload cavity radiotherapy NOS (5A6Z.)
  • Afterload radioth.- OP cavity (5A67.)
  • Afterload radiotherapy - female genital (5A64.)
  • Afterload radiotherapy - head (5A61.)
  • Afterload radiotherapy - rectum (5A66.)
  • Afterload radiotherapy - respiratory system (5A63.)
  • Afterload radiotherapy - upper gastrointestinal tract (5A62.)
  • Afterload radiotherapy - urinary (5A65.)
  • Afterloading cavity radiotherapy (5A6..)
  • Betatron X-ray therapy (Ub0w8)
  • Betatron electron teletherapy (Ub0wK)
  • Bone marrow suppression - irradiation (5A13.)
  • Bone tumour/metastasis irradiation (5A15.)
  • Brachytherapy (8J0..)
  • Caesium 137 brachytherapy (Ub0wT)
  • Caesium 137 brachytherapy manual loading (Ub0wU)
  • Caesium 137 brachytherapy manual loading Heyman's capsules (Ub0wV)
  • Caesium 137 brachytherapy remote afterloading (XaDok)
  • Caesium 137 teletherapy (Ub0wC)
  • Calculation of brachytherapy (Ub0xN)
  • Calculation of radionuclide therapy (Ub0xO)
  • Calculation of radiotherapy dose corrections (Ub0xL)
  • Calculation of radiotherapy dose-volume histogram (Ub0xM)
  • Calculation of radiotherapy isodose distribution (Ub0xK)
  • Calculation of teletherapy (Ub0xH)
  • Calculation of teletherapy parameters (Ub0xI)
  • Californium 252 brachytherapy (Ub0we)
  • Cathetron brachytherapy (Ub0wZ)
  • Cobalt 60 brachytherapy (Ub0wX)
  • Cobalt 60 brachytherapy manual loading (Ub0wY)
  • Cobalt 60 brachytherapy remote afterloading (XaDol)
  • Cobalt 60 teletherapy (Ub0wD)
  • Combined internal radiotherapy (5A17.)
  • Combined radiotherapy (597..)
  • Combined radiotherapy NOS (597Z.)
  • Curietron brachytherapy (Ub0wW)
  • Cyclotron neutron teletherapy (Ub0wO)
  • Delivery fraction complex radiotherapy megavoltage machine (XaLzu)
  • Delivery fraction radiotherapy superficial orthovoltage mach (XaLzw)
  • Delivery fraction simple radiotherapy megavoltage machine (XaLzv)
  • Delivery of a fraction of external beam radiotherapy NEC (XaMtr)
  • Delivery of a fraction of interstitial radiotherapy (XaM2F)
  • Delivery of a fraction of intracavitary radiotherapy (XaM2E)
  • Delivery of a fraction of intraluminal brachytherapy (XaPw8)
  • Delivery of a fraction of total body irradiation (TBI) (XaM2C)
  • Deuterium on tritium neutron teletherapy (Ub0wP)
  • Distant gamma therapy NOS (595Z.)
  • Electron teletherapy (Ub0wI)
  • External radiotherapy NOS (59Z..)
  • Fast-electron therapy (593..)
  • Fast-electron therapy NOS (593Z.)
  • Gamma ray and intermediate distance curietherapy (595..)
  • Gamma ray teletherapy (Ub0wB)
  • Gammamed brachytherapy (Ub0wb)
  • Give radiosensitising drug (5A81.)
  • Gold 198 brachytherapy (Ub0wf)
  • Gold 198 therapy (Ub0wu)
  • Grenz ray therapy (Ub0w4)
  • Heavy ion teletherapy (XaDot)
  • Heavy particle therapy (594..)
  • Heavy particle therapy NOS (594Z.)
  • High dose brachytherapy (XaIl6)
  • High-energy beam therapy (592..)
  • High-energy beam therapy NOS (592Z.)
  • Hiletron neutron teletherapy (Ub0wQ)
  • Hypofractionated SRT using megavoltage radiation (Xaaqq)
  • Internal metabolic radiotherapy (5A1..)
  • Internal metabolic radiotherapy NOS (5A1Z.)
  • Internal radiotherapy - permanent seeds (5A3..)
  • Internal radiotherapy - unsealed source (5A2..)
  • Internal unsealed radiotherapy NOS (5A2Z.)
  • Iodine 125 brachytherapy (Ub0wg)
  • Iodine 131 meta-iodobenzylguanidine therapy (Ub0ws)
  • Iodine 131 therapy (Ub0wq)
  • Iodine seed radiotherapy (XaImG)
  • Iridium 192 brachytherapy (Ub0wa)
  • Iridium 192 brachytherapy remote afterloading (XaDor)
  • Iridium wire therapy (XaIpE)
  • Linear accelerator X-ray therapy (Ub0w7)
  • Linear accelerator electron teletherapy (Ub0wJ)
  • Making of beam direction shell for radiotherapy (Ub0x7)
  • Making of bite block for radiotherapy (Ub0x8)
  • Making of bolus block for radiotherapy (Ub0x9)
  • Making of compensator for radiotherapy (Ub0xA)
  • Making of cut-out for radiotherapy (Ub0xB)
  • Making of docking unit for radiotherapy (Ub0xC)
  • Making of shielding block for radiotherapy (Ub0xE)
  • Making of surface mould for brachytherapy (Ub0xF)
  • Making of template for radiotherapy (Ub0xD)
  • Megavoltage X-ray therapy (Ub0w6)
  • Megavoltage treatment for adaptive radiotherapy (XaPvh)
  • Megavoltage treatment for complex radiotherapy (XaPve)
  • Megavoltage treatment for simple radiotherapy (XaPvf)
  • Microselectron brachytherapy (Ub0wc)
  • Microtron X-ray therapy (Ub0w9)
  • Microtron electron teletherapy (Ub0wL)
  • Neutron teletherapy (Ub0wN)
  • Oral delivery of radiotherapy for thyroid ablation (XaMuE)
  • Orthovoltage X-ray therapy (Ub0w5)
  • Oth spec rad vol definition ([AND/OR] prep for ext beam rad) (XaM2Z)
  • Other nuclear therapy (XE2rh)
  • Other nuclear therapy NOS (5AZ..)
  • Other radiotherapy NOS (5A8Z.)
  • Other radiotherapy misc. (5A8..)
  • Other spec rad prep ([AND/OR] other spec prep ext beam rad) (XaM2Q)
  • Other specified preparation for brachytherapy (XaPuW)
  • Other specified preparation for external beam radiotherapy (XaPuQ)
  • Other specified radiotherapy delivery (XaM2G)
  • Other specified radiotherapy procedures (XaLzs)
  • Other specified support for preparation for radiotherapy (XaPvj)
  • Outlining for radiotherapy dose calculation (Ub0xJ)
  • Palliative course of deep X-ray therapy (XaFBN)
  • Phosphorus 32 brachytherapy (Ub0wh)
  • Phosphorus 32 therapy (Ub0wr)
  • Polycythaemia irradiation (5A14.)
  • Postoperative course of deep X-ray therapy (XaFBP)
  • Preload cavity radiotherapy - sealed (5A5..)
  • Preload cavity radiotherapy NOS (5A5Z.)
  • Preload radioth.- OP cavity (5A5B.)
  • Preload radiotherapy - ear (5A55.)
  • Preload radiotherapy - female genital (5A58.)
  • Preload radiotherapy - mouth (5A54.)
  • Preload radiotherapy - nose (5A53.)
  • Preload radiotherapy - orbit (5A51.)
  • Preload radiotherapy - paranasal sinus (5A52.)
  • Preload radiotherapy - rectum (5A5A.)
  • Preload radiotherapy - respiratory organs (5A57.)
  • Preload radiotherapy - upper gastrointestinal tract (5A56.)
  • Preload radiotherapy - urinary system (5A59.)
  • Preoperative course of deep X-ray therapy (XaFBO)
  • Prep ([AND/OR] vol de sup deep X-ray, ele megav rad si calc) (XaM2Y)
  • Prep ([AND/OR] vol def for radioth with imag, dos tech supp) (XaM2U)
  • Prep ([AND/OR] vol def mult phases complx radioth with dosim (XaM2V)
  • Prep ([AND/OR] vol def radiotherapy imag and IMRT dosimetry) (XaM2T)
  • Prep for interstitial radiotherapy ([AND/OR] brachytherapy) (XaM2P)
  • Prep for intracavitary radiotherapy ([AND/OR] brachytherapy) (XaM2O)
  • Prep for simple radioth with imaging and simple calculation (XaPuN)
  • Prepar for superficial radiotherapy with simple calculation (XaPuO)
  • Preparation for brachytherapy (XaPuS)
  • Preparation for brachytherapy NOS (XaPuX)
  • Preparation for complex conformal radiotherapy (XaPuP)
  • Preparation for external beam radiotherapy (XaPuI)
  • Preparation for external beam radiotherapy NOS (XaPuR)
  • Preparation for hemi body irradiation (XaPuL)
  • Preparation for intensity modulated radiation therapy (XaPuJ)
  • Preparation for interstitial brachytherapy (XaPuV)
  • Preparation for intracavitary brachytherapy (XaPuU)
  • Preparation for intraluminal brachytherapy (XaPuT)
  • Preparation for simp radiotherapy with imaging and dosimetry (XaPuM)
  • Preparation for total body irradiation (XaM2N)
  • Proton teletherapy (Ub0wR)
  • Pulsed dose rate brachytherapy (Xaawm)
  • Purpose of radiotherapy (514..)
  • Rad prep ([AND/OR] prep for ext beam rad AND/OR brachythera) (XaM2M)
  • Rad vol defin ([AND/OR] prep for externl beam radiother) NOS (XaM2a)
  • Radio vol definition ([AND/OR] prep ex beam radio OR brachy) (XaM2S)
  • Radioactive drug therapy (5A16.)
  • Radioactive drug therapy (& I131) (XE1Rx)
  • Radioactive iodine therapy (XC0gO)
  • Radiochemotherapy NOS (5A7Z.)
  • Radiochemotherapy: IV route (5A74.)
  • Radiochemotherapy: for immunosuppression (5A75.)
  • Radiochemotherapy: into cavity (5A77.)
  • Radiochemotherapy: local artery (5A76.)
  • Radiochemotherapy: local infiltration (5A71.)
  • Radiochemotherapy: oral route (5A73.)
  • Radiochemotherapy: to stop spread (5A72.)
  • Radiolabelled antibody therapy (XaDn2)
  • Radiomimetic chemotherapy (5A7..)
  • Radionuclide therapy (Ub0wo)
  • Radioprotective drug (5A83.)
  • Radiosensitising measure (5A82.)
  • Radiotherapy (Xa8SI)
  • Radiotherapy - internal (Xa97L)
  • Radiotherapy NEC (7M371)
  • Radiotherapy by body site (XaNSR)
  • Radiotherapy calculation (Ub0xG)
  • Radiotherapy delivery (XaM2B)
  • Radiotherapy delivery NOS (XaM2H)
  • Radiotherapy mould room procedure (XaDp8)
  • Radiotherapy planning (Ub0wv)
  • Radiotherapy planning using a free set up (Ub0ww)
  • Radiotherapy planning using a simulator (Ub0wx)
  • Radiotherapy planning using a simulator X-ray film (Ub0wz)
  • Radiotherapy planning using computerised tomography (Ub0x4)
  • Radiotherapy planning using diagnostic radiology (Ub0x0)
  • Radiotherapy planning using magnetic resonance imaging (Ub0x5)
  • Radiotherapy planning using mould room preparation (Ub0x6)
  • Radiotherapy planning using simulator fluoroscopy (Ub0wy)
  • Radiotherapy procedures NOS (XaLzt)
  • Radiotherapy purpose - NOS (514Z.)
  • Radiotherapy to abdomen (Y036f)
  • Radiotherapy to abdomen (XaNS6)
  • Radiotherapy to axilla (Y036b)
  • Radiotherapy to axilla (XaNSA)
  • Radiotherapy to bone (Y037b)
  • Radiotherapy to breast (Y036a)
  • Radiotherapy to breast (XaNSB)
  • Radiotherapy to chest wall (XaNS8)
  • Radiotherapy to chest wall (Y036d)
  • Radiotherapy to head (Y035e)
  • Radiotherapy to head (XaNSC)
  • Radiotherapy to neck (XaNS7)
  • Radiotherapy to neck (Y035f)
  • Radiotherapy to pelvis (XaNSD)
  • Radiotherapy to pelvis (Y036e)
  • Radiotherapy to perineum (Y037a)
  • Radiotherapy to perineum (XaNS5)
  • Radiotherapy to subclavia (Y036c)
  • Radiotherapy treatment groups (8J...)
  • Radiotherapy: endolymphatic infusion (5A25.)
  • Radiotherapy: infiltrate tissue (5A28.)
  • Radiotherapy: infuse head/neck (5A22.)
  • Radiotherapy: infuse organ cavity (5A27.)
  • Radiotherapy: infuse peritoneal cavity (5A24.)
  • Radiotherapy: infuse pleural cavity (5A23.)
  • Radiotherapy: infuse skull/brain (5A21.)
  • Radiotherapy: infuse urinary bladder (5A26.)
  • Radiotherapy: permanent seeds NOS (5A3Z.)
  • Radiotherapy: seeds into brain (5A32.)
  • Radiotherapy: seeds into cavity (5A33.)
  • Radiotherapy: seeds into hypophysis (5A31.)
  • Radiotherapy: temporary abdominal implant (5A45.)
  • Radiotherapy: temporary brain implant (5A41.)
  • Radiotherapy: temporary head/neck implant (5A42.)
  • Radiotherapy: temporary implant NOS (5A4Z.)
  • Radiotherapy: temporary limb implant (5A47.)
  • Radiotherapy: temporary lymphatic implant (5A48.)
  • Radiotherapy: temporary pelvic implant (5A46.)
  • Radiotherapy: temporary thorax implant (5A44.)
  • Radiotherapy: temporary tongue implant (5A43.)
  • Radiothp prep NOS ([AND/OR] prep for ext beam radiothp NOS) (XaM2R)
  • Radium 226 brachytherapy (Ub0wi)
  • Radium 226 teletherapy (Ub0wG)
  • Radon 222 brachytherapy (Ub0wj)
  • Ruthenium 106 brachytherapy (Ub0wk)
  • Seed implantation into prostate (XaMOH)
  • Selectron brachytherapy (Ub0wd)
  • Selectron therapy (XaIpD)
  • Short distance and contact radiotherapy (596..)
  • Short distance/contact radiotherapy NOS (596Z.)
  • Stereotactic cobalt teletherapy (Ub0wF)
  • Stereotactic radiosurgery on tissue of brain (XaLbh)
  • Stereotactic radiotherapy (XaIpe)
  • Strontium 89 therapy (Ub0wt)
  • Strontium 90 brachytherapy (Ub0wl)
  • Strontium 90 electron teletherapy (Ub0wM)
  • Superficial X-ray therapy (Ub0w2)
  • Superficial or orthovoltage treatment for radiotherapy (XaPvg)
  • Support for preparation for radiotherapy (XaPvl)
  • Support for preparation for radiotherapy NOS (XaPvk)
  • Tantalum 182 brachytherapy (Ub0wm)
  • Technical support for preparation for radiotherapy (XaPvi)
  • Teletherapy (8J1..)
  • Teletherapy with dual headed cobalt unit (Ub0wE)
  • Teletherapy with radium collar (Ub0wH)
  • Temporary implant radiotherapy (XE2r3)
  • Thyroid gland ablation - irradiation (5A11.)
  • Thyroid tumour/metastasis irradiation (5A12.)
  • Treatment planning for brachytherapy (XS90X)
  • Treatment planning for teletherapy (XaFz7)
  • Van der Graaff X-ray therapy (Ub0wA)
  • Vol def ([AND/OR] prep for simpl radioth with imag dosimtry) (XaM2W)
  • Vol defin ([AND/OR] prep) for simp radio imag and simpl calc (XaM2X)
  • X-ray beam therapy (591..)
  • X-ray beam therapy NOS (591Z.)
  • X-ray teletherapy (XaDn1)
  • Yttrium 90 brachytherapy (Ub0wn)
  • Yttrium 90 therapy (Ub0wp)
• Radiotherapy to ciliary body (X00X9)
• Radiotherapy to lacrimal gland (72201)
• Radiotherapy to lesion of canthus (Xa7mv) with these descendants
  • Radiotherapy to lesion of lateral canthus (X00UQ)
  • Radiotherapy to lesion of medial canthus (X00U8)
• Radiotherapy to lesion of choroid (X00Y8)
• Radiotherapy to lesion of peripheral nerve (70522)
• Radiotherapy to orbital lesion (X00Te)
• Radiotherapy to retina (X00Xi) with these descendants
  • External beam radiotherapy to lesion of retina (XaLuJ)
  • Plaque radiotherapy to lesion of retina (XaL5K)
  • Radiotherapy to lesion of retina (72722)
• Referred for radiotherapy (8H67.)
• Seen in radiotherapy clinic (9N1yC)
• Selective internal radiotherapy microspheres lesion of liver (XaLdq)
• Subcutaneous chemotherapy (XE0Je)
• Transurethral radiofrequency needle ablation of prostate (XaMB1)
• [V]Chemotherapy follow-up (ZV672)
• [V]Chemotherapy session for neoplasm (ZV588)
• [V]Convalescence after radiotherapy (ZV661)
• [V]Follow-up exam aft combined treatment for malig neoplasm (ZV679)
• [V]Follow-up exam after chemotherapy for other conditions (ZV6B1)
• [V]Follow-up examin after chemotherapy for malign neoplasm (ZV678)
• [V]Maintenance chemotherapy (ZV581)
• [V]Other prophylactic chemotherapy (ZV073)
• [V]Radiotherapy session (ZV580)
• [X]Antineoplast antimetabs caus adverse eff in therap use (U6031)
• [X]Antineoplast natural prod caus adverse eff in therap use (U6032)
• [X]Follow-up examinat after chemother for other conditions (ZVu0D)
• [X]Follow-up examinat after radiother for other conditions (ZVu0C)
• [X]Other antineoplast drugs caus adverse eff in therap use (U6033)
• [X]Other chemotherapy (ZVu3L)
• [X]Overdose of radiation given during therapy (U6132)